Company biote Corp.

Equities

BTMD

US0906831039

Professional Information Services

Business Summary

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-17 pm EDT			5-day change	1st Jan Change
5.75 ^USD	-1.54%		-6.05%	+16.40%

May. 10	Biote Corp. acquired Certain assets of BioSana ID LLC for $0.8 million.	CI
May. 07	Earnings Flash (BTMD) BIOTE Reports Q1 Revenue $46.8M, vs. Street Est of $45.7M	MT

biote Corp. operates a practice-building business within the hormone optimization space. The Company provides the necessary components to enable Biote-certified practitioners to establish, build and implement a program designed to optimize hormone levels using personalized solutions for their patient populations. The Biote Method is a comprehensive, end-to-end practice building platform that provides Biote-certified practitioners with the components specifically developed for practitioners in the hormone optimization space: Biote Method education, training and certification, practice management software, inventory management software, and information regarding available hormone replacement therapy (HRT) products, as well as digital and point-of-care marketing support. It also sells a complementary Biote-branded line of dietary supplements. The Biote Methodâs proprietary clinical decision support (CDS) software assists physicians in establishing individualized dosing for patients.

Number of employees: 194

Managers	Title	Age	Since
Teresa Weber CEO	Chief Executive Officer	71	22-04-30
Robert Peterson DFI	Director of Finance/CFO	47	Jan. 07
Joe Butler CTO	Chief Tech/Sci/R&D Officer	62	19-05-31
Ross W. McQuivey CTO	Chief Tech/Sci/R&D Officer	52	22-06-09
Mary Puncochar PRN	Corporate Officer/Principal	-	23-05-29
Jennifer Schimmel HRO	Human Resources Officer	51	-
Mary Conlon LAW	General Counsel	44	21-05-31
Richard K. Key SAM	Sales & Marketing	54	-
Jade Beutler PRN	Corporate Officer/Principal	61	22-04-30

Members of the board	Title	Age	Since
Steven Heyer BRD	Director/Board Member	71	22-04-30
Andrew Heyer BRD	Director/Board Member	66	22-04-30
Marc Beer CHM	Chairman	59	22-04-30
Debra L. Morris BRD	Director/Board Member	65	22-11-02
Teresa Weber CEO	Chief Executive Officer	71	22-04-30
Dana Jacoby BRD	Director/Board Member	49	22-04-30
S. Mark Cone BRD	Director/Board Member	61	22-04-30

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	41,715,880	0	10,000,000 ( 23.97 %)	66.80 %
Stock B	1	31,908,099	21,316,017 ( 66.80 %)	1,587,500 ( 4.975 %)

Name	Equities	%	Valuation
325 Capital LLC 10.55 %	3,766,666	10.55 %	21 M $
Roystone Capital Management LP 8.599 %	3,070,938	8.599 %	17 M $
Bandera Partners LLC 5.615 %	2,005,322	5.615 %	11 M $
Haymaker Sponsor III LLC 5.232 %	1,868,556	5.232 %	10 M $
Vanguard Fiduciary Trust Co. 3.934 %	1,404,914	3.934 %	8 M $
FPR Partners LLC 3.082 %	1,100,766	3.082 %	6 M $
BlackRock Advisors LLC 2.641 %	943,195	2.641 %	5 M $
Kanen Wealth Management LLC 2.346 %	837,643	2.346 %	5 M $
Boston Partners Global Investors, Inc. 1.999 %	713,741	1.999 %	4 M $
Wasatch Advisors, Inc. 1.876 %	669,861	1.876 %	4 M $

biote Corp.

1875 West Walnut Hill Lane Suite 100

75038, Irving

http://www.biote.com

Industrials

Industrial & Commercial Services

Professional & Commercial Services

Professional Information Services

Education & Training Information Providers